Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 vaccines: where we stand and challenges ahead
Guido Forni, Alberto Mantovani
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 626-639
Open Access | Times Cited: 775

Showing 1-25 of 775 citing articles:

Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts
Jeremiah Chakaya, Mishal Khan, Francine Ntoumi, et al.
International Journal of Infectious Diseases (2021) Vol. 113, pp. S7-S12
Open Access | Times Cited: 887
Vaccine hesitancy: Beliefs and barriers associated with COVID‐19 vaccination among Egyptian medical students
Shimaa M. Saied, Eman M. Saied, Ibrahim Kabbash, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 7, pp. 4280-4291
Open Access | Times Cited: 454
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
Kizzmekia S. Corbett, Martha Nason, Britta Flach, et al.
Science (2021) Vol. 373, Iss. 6561
Open Access | Times Cited: 302
Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Ali Pormohammad, Mohammad Zarei, Saied Ghorbani, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 467-467
Open Access | Times Cited: 300
CORONAVIRUS DISEASE 2019 (COVID-19): A LITERATURE REVIEW
Bashar Ibrahım, Ebru Önem
Gevher Nesibe Journal IESDR (2021) Vol. 6, Iss. 12, pp. 56-72
Closed Access | Times Cited: 249
Side effects and perceptions following Sinopharm COVID-19 vaccination
Balsam Qubais Saeed, Rula Al‐Shahrabi, Shaikha Salah Alhaj, et al.
International Journal of Infectious Diseases (2021) Vol. 111, pp. 219-226
Open Access | Times Cited: 245
Covid-19 vaccines production and societal immunization under the serendipity-mindsponge-3D knowledge management theory and conceptual framework
Quan‐Hoang Vuong, Tam-Tri Le, Viet‐Phuong La, et al.
Humanities and Social Sciences Communications (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 204
Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
Nicholas G. Kounis, Ioanna Koniari, Cesare de Gregorio, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 221-221
Open Access | Times Cited: 186
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 156
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, et al.
Food and Chemical Toxicology (2022) Vol. 164, pp. 113008-113008
Open Access | Times Cited: 152
Safety of COVID-19 vaccines administered in the EU: Should we be concerned?
Antonio F. Hernández, Daniela Călina, Konstantinos Poulas, et al.
Toxicology Reports (2021) Vol. 8, pp. 871-879
Open Access | Times Cited: 136
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
Xinle Cui, Clifford M. Snapper
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 131
Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer–BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines
Sandhya Bansal, Sudhir Perincheri, Timothy P. Fleming, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 10, pp. 2405-2410
Open Access | Times Cited: 127
The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines
Mehrdad Mohammadi, Mohammad Shayestehpour, Hamed Mirzaei
The Brazilian Journal of Infectious Diseases (2021) Vol. 25, Iss. 4, pp. 101606-101606
Open Access | Times Cited: 126
The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland
Piotr Rzymski, Joanna Zeyland, Barbara Poniedziałek, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 382-382
Open Access | Times Cited: 123
Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum
Timothy A. Bates, Hans C. Leier, Zoë L. Lyski, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 123
Investigating COVID-19 News Across Four Nations: A Topic Modeling and Sentiment Analysis Approach
Piyush Ghasiya, Koji Okamura
IEEE Access (2021) Vol. 9, pp. 36645-36656
Open Access | Times Cited: 115
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines
Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo
Molecular Pharmaceutics (2021) Vol. 18, Iss. 8, pp. 2867-2888
Open Access | Times Cited: 115
Immune response in COVID-19: what is next?
Qing Li, Ying Wang, Qiang Sun, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1107-1122
Open Access | Times Cited: 115
Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential
Bjoern Meyer, Jeanne Chiaravalli, Stacy Gellenoncourt, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 111
Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay
Elena Riester, Peter Findeisen, Johannes Kolja Hegel, et al.
Journal of Virological Methods (2021) Vol. 297, pp. 114271-114271
Open Access | Times Cited: 109
A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, et al.
VirusDisease (2022) Vol. 33, Iss. 1, pp. 1-22
Open Access | Times Cited: 103
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals
Marie I. Samanovic, Amber Cornelius, Sophie L. Gray-Gaillard, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 631
Open Access | Times Cited: 88
SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress
Katharina M. Scherer, Luca Mascheroni, George Carnell, et al.
Science Advances (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 87
mRNA vaccines for COVID-19 and diverse diseases
Abid Hussain, Haiyin Yang, Jun Zhang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 314-333
Open Access | Times Cited: 85
Page 1 - Next Page

Scroll to top